rs199934107
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_145045.5(ODAD3):c.1203G>A(p.Arg401Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000511 in 1,611,840 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0025 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00030 ( 2 hom. )
Consequence
ODAD3
NM_145045.5 synonymous
NM_145045.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.19
Publications
0 publications found
Genes affected
ODAD3 (HGNC:28303): (outer dynein arm docking complex subunit 3) This gene encodes a protein containing coiled-coil domains. The encoded protein functions in outer dynein arm assembly and is required for motile cilia function. Mutations in this gene result in primary ciliary dyskinesia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]
ODAD3 Gene-Disease associations (from GenCC):
- primary ciliary dyskinesia 30Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 19-11422775-C-T is Benign according to our data. Variant chr19-11422775-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 414141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.18 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0025 (381/152346) while in subpopulation AFR AF = 0.00858 (357/41586). AF 95% confidence interval is 0.00785. There are 1 homozygotes in GnomAd4. There are 167 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ODAD3 | NM_145045.5 | c.1203G>A | p.Arg401Arg | synonymous_variant | Exon 9 of 13 | ENST00000356392.9 | NP_659482.3 | |
| ODAD3 | NM_001302453.1 | c.1041G>A | p.Arg347Arg | synonymous_variant | Exon 9 of 13 | NP_001289382.1 | ||
| ODAD3 | NM_001302454.2 | c.1023G>A | p.Arg341Arg | synonymous_variant | Exon 7 of 11 | NP_001289383.1 | ||
| ODAD3 | XM_017026241.2 | c.*97G>A | downstream_gene_variant | XP_016881730.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ODAD3 | ENST00000356392.9 | c.1203G>A | p.Arg401Arg | synonymous_variant | Exon 9 of 13 | 1 | NM_145045.5 | ENSP00000348757.3 |
Frequencies
GnomAD3 genomes AF: 0.00250 AC: 381AN: 152228Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
381
AN:
152228
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000725 AC: 175AN: 241490 AF XY: 0.000576 show subpopulations
GnomAD2 exomes
AF:
AC:
175
AN:
241490
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000303 AC: 442AN: 1459494Hom.: 2 Cov.: 32 AF XY: 0.000247 AC XY: 179AN XY: 726108 show subpopulations
GnomAD4 exome
AF:
AC:
442
AN:
1459494
Hom.:
Cov.:
32
AF XY:
AC XY:
179
AN XY:
726108
show subpopulations
African (AFR)
AF:
AC:
344
AN:
33476
American (AMR)
AF:
AC:
19
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
AC:
19
AN:
26126
East Asian (EAS)
AF:
AC:
0
AN:
39694
South Asian (SAS)
AF:
AC:
0
AN:
86254
European-Finnish (FIN)
AF:
AC:
0
AN:
51218
Middle Eastern (MID)
AF:
AC:
6
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
15
AN:
1111878
Other (OTH)
AF:
AC:
39
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
28
56
83
111
139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00250 AC: 381AN: 152346Hom.: 1 Cov.: 32 AF XY: 0.00224 AC XY: 167AN XY: 74504 show subpopulations
GnomAD4 genome
AF:
AC:
381
AN:
152346
Hom.:
Cov.:
32
AF XY:
AC XY:
167
AN XY:
74504
show subpopulations
African (AFR)
AF:
AC:
357
AN:
41586
American (AMR)
AF:
AC:
15
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
5
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5190
South Asian (SAS)
AF:
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2
AN:
68026
Other (OTH)
AF:
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
21
42
62
83
104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Primary ciliary dyskinesia 30 Benign:2
Aug 21, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Dec 26, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.